For research use only. We do not sell to patients.
Bosutinib D8
Biological Activity：Bosutinib D8 (SKI-606 D8) is a deuterium labeled Bosutinib. Bosutinib is a dual Src/Abl inhibitor with IC50s of 1.2 nM and 1 nM, respectively[2].
Research Area：Cancer
Targets：Autophagy|Bcr-Abl|Src
Related Small Molecules:KB SRC 4;Tirbanibulin dihydrochloride;AT9283;Bafetinib;Pivanex;p60c-src substrate II;SNIPER(ABL)-039;Flumatinib mesylate;IHMT-TRK-284;Caffeic acid-pYEEIE TFA;PP2;PP58;SNIPER(ABL)-049;Olverembatinib;ENMD-2076 Tartrate;CH6953755;GNF-2;CT-721;SNIPER(ABL)-015;GNF-5;Fenlean;TL02-59;BCR-ABL-IN-4;A-770041;SNIPER(ABL)-033;PF 477736;CHMFL-ABL-039;PD166326
Trending products：Recombinant Proteins | Bioactive Screening Libraries | Natural Products | Fluorescent Dye | PROTAC | Isotope-Labeled Compounds | Oligonucleotides
About Us:
- MedChemExpress (MCE) offers a wide range of high-quality research chemicals and biochemicals (novel life-science reagents, reference compounds and natural compounds) for scientific use；
- Structurally and synthetically diverse biologically active compounds；
- roduct quality is the key to our success and we take pride in offering only the highest-grade products.；
- We provide HNMR, LC-MS, HPLC, stability testing and activity assays of our products to clients.；
- Product identity, quality, purity and activity are assured by our robust quality control programs and procedures.；
- Customized order volume ranging from milligrams to kilograms scale；
Structurally and synthetically diverse biologically active compounds；
We provide customer-oriented services. To explore more, please contact us at [email protected]. Our team will gladly assist you.
